Le Lézard
Classified in: Health
Subjects: CHI, PDT, DEI

InventHelp Inventors Develop New Fever Pops for Children (AJD-203)


PITTSBURGH, Feb. 14, 2024 /PRNewswire/ -- "I work at a children's hospital and thought there could be a way to administer necessary medications to a young child by taking advantage of their natural affinity for sweet treats," said one of two inventors, from Fairburn, Ga., "so we invented the FEVER POPS. Our flavorful design would help reduce fever and pain while also providing added hydration."

The patent-pending invention provides a new way to administer ibuprofen or acetaminophen to children. In doing so, it enhances convenience, flavor and fun. As a result, it enables the correct dosage to be administered without a fuss. It also offers the added benefit of cooling and hydrating young patients with fevers. The invention features a unique design that is easy to consume so it is ideal for parents with young children, hospitals, etc. Additionally, it is producible in design variations.

The original design was submitted to the Atlanta sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 22-AJD-203, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.

SOURCE InventHelp


These press releases may also interest you

at 04:00
Uniken, a leading provider of security, authentication, and identity verification, announces at the Temenos Community Forum 2024 the release of Palm Vein Authentication for in-branch, rural and inclusive banking on its REL-ID platform. Financial...

at 03:55
A groundbreaking study, published in the scientific journal Advanced Materials, on 6 May 2024, led by researchers of VTT Technical Research Centre of Finland, introduces a transformative approach that integrates synthetic biology with advanced...

at 03:05
MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today announced it will present positive data for its lead asset, MH002, a live microbial consortium therapy...

at 03:00
Viewpoint, the esteemed educational program hosted by renowned actor Dennis Quaid, is excited to announce a partnership with Liberty Athletic Club in Ann Arbor, MI, for an upcoming episode dedicated to highlighting the positive impact of offering a...

at 02:36
Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 116.8 million in the first quarter of 2024 (Q1 2023: NOK 105.9 million), and EBITDA of NOK 7.9 million (NOK -1.2 million) following positive operational developments and cost...

at 02:35
Exciting news from Meril Life Sciences! The LANDMARK trial's 30 days primary outcomes were presented on 15th May at EuroPCR 2024, Paris, France. LANDMARK was...



News published on and distributed by: